We are excited to announce that we are speaking at the Explore Cell 2024: Advancing Future Insights in Cell & Gene Research in London this November, 2024!
Join us for insightful discussions on advancements in every step of the CGT value chain.
Speaking from the Cell and Gene Therapy Catapult
06 NOVEMBER 2024
Title: Investor-Focused Panel Session: Mapping The Future of CGT Investment: Strategies For Funding & Reimbursement
Moderator: Sam Goldsmith, Head of Commercialisation of Research & Investments
Time: 3-3:50PM
Panel Discussion: Cryopreservation Techniques & Transportation: Safeguarding Cell Viability In ATMP Development
Panellist: Mahdieh Hassanjani, Innovation Project Manager
Time: 5:40-6:30PM
Panel Discussion: CGT IP Challenges
Panellist: Matthew Garner, Head of Intellectual Property
Time: 17:40-18:30
07 NOVEMBER 2024
TRACK 5: STRATEGIES FOR GENE THERAPY MANUFACTURING & PRODUCTION
Title: Manufacturing Multiple ATMP Modalities In The Same Facility
Speaker: Himansu Patel, Head Of Quality Innovation
Time: 12:05 – 12:30
TRACK 1: CELL LINE ENGINEERING & DEVELOPMENT
Title: Cell Line Engineering For AAV Development
Track chair: Himansu Patel, Head Of Quality Innovation
Speaker: Ele Zucchelli, Associate Lead Scientist
Time: 12:55 – 13:20
Panel Discussion: How To Troubleshoot Cell Line Engineering & Development Bottlenecks
Panellist: Ele Zucchelli, Associate Lead Scientist
Time: 16:35-17:00
08 NOVEMBER 2024
TRACK 2: PRECLINICAL CGT ASSESSMENTS: RESEARCH & DEVELOPMENT
Track chair: Himansu Patel, Head Of Quality Innovation